Finance Desk – Sagility India, a healthcare services company in Bengaluru, is about to start its public stock sale, known as an IPO, on November 5. Before this sale, its parent company sold shares for ₹366 crore to prepare for the IPO.
They sold these shares at ₹30 each, which is the maximum price they hope to get when the IPO starts. They’re looking to raise ₹2,107 crore in total from this IPO.
Here’s the plan: The IPO is just selling shares that already exist, not creating new ones. This means the original owners are selling some of their shares to other people. Regular people can buy shares for about ₹15,000, but bigger investors have to spend at least ₹2,10,000.
Out of all the shares, 75% are for large investors, 10% for regular people, and 15% for other large investors.
Looking at Sagility’s finances, from April to June 2024, they made ₹1,247.76 crore and their profit was ₹22.29 crore. Their earnings for the year increased by 12% to ₹4,781.5 crore, and their profits rose by 59% to ₹228.27 crore.
While Sagility doesn’t really face direct competition in India, it does compete with other global healthcare companies and large IT firms.
They provide services like managing healthcare claims and payments for US-based health companies and operate from India, the Philippines, the US, Jamaica, and Colombia.
Experts are watching to see how well Sagility India will do in this uncertain market. The IPO ends on November 7, and the company plans to list its shares on the stock markets in India on November 12.
